The results showed that 3 clinicopathologic factors (age, The Eastern Cooperative Oncology Group, and bone metastasis) and 3 genes (EGFR, HER2, MYC) have significant correlation with PFS (Table 2). This evidence concerns the gene ERBB2 and bone metastasis.